Back
Compagnie Financiere Richemont SA Vs. NovoCure Industry Stock Comparison
Sell
37
CFRUY
Compagnie Financiere Richemont SA
Last Price:
14.61
Seasonality Move:
6.19%
Buy
77
NVCR
NovoCure
Last Price:
28.82
Seasonality Move:
2.04%
Sell
37
Compagnie Financiere Richemont SA (CFRUY)
is a Sell
Is Compagnie Financiere Richemont SA a Buy, Sell or Hold?
- The current Compagnie Financiere Richemont SA [CFRUY] share price is $14.41. The Score for CFRUY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- CFRUY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CFRUY Stock Price Chart
What is Compagnie Financiere Richemont SA's stock price today?
-
The Compagnie Financiere Richemont SA share price today is $14.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CFRUY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVCR Stock Price Chart
CFRUY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 59.38 | Buy |
Chaikin Money Flow: | 1451557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.38 - 14.4) | Buy |
Bollinger Bands (100): | (13.91 - 15.45) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.24 | Buy |
Relative Strength Index (14 RSI): | 84.56 | Buy |
Chaikin Money Flow: | -690353 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.69 - 22.01) | Buy |
Bollinger Bands (100): | (15.44 - 20.28) | Buy |
CFRUY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.75 | Buy |
20-day SMA: | 13.72 | Buy |
50-day SMA: | 14.42 | Sell |
200-day SMA: | 15.02 | Sell |
8-day EMA: | 13.91 | Buy |
20-day EMA: | 13.88 | Buy |
50-day EMA: | 14.22 | Buy |
200-day EMA: | 14.65 | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.45 | Buy |
20-day SMA: | 18.85 | Buy |
50-day SMA: | 17.12 | Buy |
200-day SMA: | 17.34 | Buy |
8-day EMA: | 23.1 | Buy |
20-day EMA: | 19.92 | Buy |
50-day EMA: | 18.23 | Buy |
200-day EMA: | 19.07 | Buy |
Compagnie Financiere Richemont SA Earnings Growth & CFRUY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.01 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
Compagnie Financiere Richemont SA Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |